0001493152-23-038415.txt : 20231026
0001493152-23-038415.hdr.sgml : 20231026
20231026171525
ACCESSION NUMBER: 0001493152-23-038415
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231016
FILED AS OF DATE: 20231026
DATE AS OF CHANGE: 20231026
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FR Capital Holdings, L.P.
CENTRAL INDEX KEY: 0001776703
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36581
FILM NUMBER: 231351026
BUSINESS ADDRESS:
STREET 1: 2400 MARKET STREET
STREET 2: SUITE 237
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 610-834-1461
MAIL ADDRESS:
STREET 1: 2400 MARKET STREET
STREET 2: SUITE 237
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Notable Labs, Ltd.
CENTRAL INDEX KEY: 0001603207
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 320 HATCH DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 415-851-2410
MAIL ADDRESS:
STREET 1: 320 HATCH DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: Vascular Biogenics Ltd.
DATE OF NAME CHANGE: 20140320
3
1
ownership.xml
X0206
3
2023-10-16
0
0001603207
Notable Labs, Ltd.
NTBL
0001776703
FR Capital Holdings, L.P.
2400 MARKET STREET,
SUITE 237
PHILADELPHIA
PA
19103
0
0
1
0
Ordinary Shares, par value NIS 0.35 each
1037345
I
See Footnote
FR Capital Holdings, L.P. (the "Reporting Person") is the investment manager to First Round Capital V, LP, a Delaware limited partnership ("FRCV"), and First Round Capital VIII-F, LP, a Delaware limited partnership ("FRCVIIIF"). Josh Kopelman and William Trenchard are the managing members of the Reporting Person. As of October 16, 2023, FRCV held 421,014 ordinary shares, par value NIS 0.35 each ("Ordinary Shares") of Notable Labs, Ltd. and FRCVIIIF held 616,331 Ordinary Shares. The Reporting Person's and Messrs. Kopelman and Trenchard's beneficial ownership is limited to their pecuniary interest, if any, in such securities.
/s/ Jeffrey Donnon, Chief Financial Officer of FR Capital Holdings, L.P.
2023-10-26